mazdutide

News

Innovent files high-dose mazdutide for obesity in China

Innovent has filed a new high-strength version of its weight-loss drug mazdutide in China, aiming to help people with severe obesity.

News

Three Chinese label boxes of Innovent's mazdutide

Pressure rises on Novo as Innovent drug tops Ozempic

Innovent's dual glucagon and GLP-1 agonist mazdutide outperforms Novo Nordisk's Ozempic in overweight people with diabetes.

News

Innovent throws its hat further into China's GLP-1 ring

Innovent Biologics is planning a second filing for its dual GLP-1/glucagon agonist mazdutide in China, as it tries to carve out a share of a market currently dominated by Novo Nordisk and E

Innovent files high-dose mazdutide for obesity in China

Pressure rises on Novo as Innovent drug tops Ozempic

Innovent throws its hat further into China's GLP-1 ring

Novartis weathers Entresto slump with return to growth

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks